6Vuksan V,Sievenpiper J.Safety and efficacy of Korean red ginseng intervention(SAEKI):results of a randomized,double blind,placebo controlled crossover trial in type 2 diabetes[J].Diabetes,2003,52(Suppl):137.
7Sievenpiper J.Korean red ginseng root-lets decrease postprandial glycemia in healthy subjects:results of an acute dose escalation study[J].Diabetes,2003,52(Suppl):387.
6ROGLIC G, UNWIN N. Mortality attributable to diabetes : estimates for the year 2010 [ J ]. Diabetes Res. Clin. Pract. , 2010,87 ( 1 ) : 15-19.
7RUBENSTRUNK A, HANF R, HUM D W, et al. Safety issues and prospects for future generations of PPAR mod- ulators [ J ]. Biochim. Biophys. Acta, 2007, 1 771 ( 8 ) : 1 065-1 081.
8ROSEN C J. Revisiting the rosiglitazone story-lessons learned[ J]. N. Engl. J. Med. ,2010,363(9) :803-806.
9COHEN D. Insiderscriticise FDA's decision not to with- draw rosiglitazone[ J ]. Brit. Med. J. ,2010,341:5 333.
10BALINT B L, NAGY L. Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases [ J ]. Endocr. Metab. Immune. Disord. Drug Target, 2006,6(1) :33-43.
